| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 4.9% | -40% | $374,355 | +$96,375 | 456,531 | +35% | CVI Investments, Inc. | 31 Mar 2025 |
| Lind Global Fund III LP | 6.4% | -35% | $187,000 | -$10,164 | 212,500 | -5.2% | Lind Global Fund III LP | 30 Sep 2025 |
| GOLDMAN SACHS GROUP INC | 2.4% | -60% | $173,795 | +$81,756 | 211,945 | +89% | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $172,058 | 209,827 | Mitchell P. Kopin | 15 Jan 2025 | |||
| Lincoln Alternative Strategies LLC | 6.2% | $127,312 | 131,250 | Lincoln Alternative Strategies LLC | 12 Sep 2025 | |||
| Wildcat Capital Management, LLC | 1.3% | $110,025 | 113,428 | Wildcat Capital Management, LLC | 26 Jun 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN). This represents 0% of the company’s total 3,320,313 outstanding shares.